Why we should care about ultra-rare disease
Orphan drugs for patients with ultra-rare diseases: between cost-effectiveness and equality of access to cure http://ow.ly/Zlmf4
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487247/ https://www.ncbi.nlm.nih.gov/pubmed/27246584 http://dx.doi.org/10.1183/16000617.0017-2016 |